CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products ...

Medical experts say getting a yearly flu vaccination is the best way to prevent flu and its potentially serious complications ...

Fintel reports that on December 12, 2025, Bernstein maintained coverage of CVS Health (NYSE:CVS) with a Market Perform ...

Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 3.2% in the morning session after the company raised ...

Given many Americans’ poor experiences with the healthcare system, CVS now hopes its new “engagement as a service” platform ...